299 related articles for article (PubMed ID: 35653821)
1. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
May T; Dawes J; Fancourt D; Burton A
Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
[TBL] [Abstract][Full Text] [Related]
2. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
4. HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.
McCrimmon T; Sundelson A; Darisheva M; Gilbert L; Hunt T; Terlikbayeva A; Primbetova S; El-Bassel N
Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487549
[TBL] [Abstract][Full Text] [Related]
5. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
6. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
[TBL] [Abstract][Full Text] [Related]
8. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
[TBL] [Abstract][Full Text] [Related]
9. Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs.
Brener L; Horwitz R; Rance J; Caruana T; Bryant J
Health Soc Care Community; 2022 Nov; 30(6):2320-2329. PubMed ID: 35293054
[TBL] [Abstract][Full Text] [Related]
10. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.
Bradley H; Austin C; Allen ST; Asher A; Bartholomew TS; Board A; Borquez A; Buchacz K; Carter A; Cooper HLF; Feinberg J; Furukawa N; Genberg B; Gorbach PM; Hagan H; Huriaux E; Hurley H; Luisi N; Martin NK; Rosenberg ES; Strathdee SA; Jarlais DCD
Int J Drug Policy; 2022 Dec; 110():103889. PubMed ID: 36343431
[TBL] [Abstract][Full Text] [Related]
11. Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya.
Masese LN; Ludwig-Barron NT; Mbogo L; Guthrie BL; Musyoki H; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
PLoS One; 2022; 17(12):e0278210. PubMed ID: 36454881
[TBL] [Abstract][Full Text] [Related]
12. Institutional violence from police militarization and drug cartel wars as a 'Big Event' and its influence on drug use harms and HIV risk in people who inject drugs on the U.S.-Mexico border.
Lechuga J; Ramos R; Dickson-Gomez J; Beachy S; Perez G; Nevola O; Varela A; Ramos ME; Sauceda J; Ludwig-Barrron N; Salazar J
Int J Drug Policy; 2023 Sep; 119():104125. PubMed ID: 37499305
[TBL] [Abstract][Full Text] [Related]
13. Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.
Williams LD; Lee E; Latkin C; Mackesy-Amiti ME; Kaufmann M; Copulsky E; Kaplan C; Boodram B
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564746
[TBL] [Abstract][Full Text] [Related]
14. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.
Wiessing L; Sypsa V; Abagiu AO; Arble A; Berndt N; Bosch A; Buskin S; Chemtob D; Combs B; Conyngham C; Feelemyer J; Fitzgerald M; Goldberg D; Hatzakis A; Patrascu RE; Keenan E; Khan I; Konrad S; Leahy J; McAuley A; Menza T; Merrick S; Metcalfe R; Rademaker T; Revivo S; Rosca P; Seguin-Devaux C; Skinner S; Smith C; Tinsley J; Wilberg M; Des Jarlais D
AIDS Behav; 2023 Apr; 27(4):1140-1153. PubMed ID: 36367613
[TBL] [Abstract][Full Text] [Related]
16. Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
Croxford S; Emanuel E; Ibitoye A; Njoroge J; Edmundson C; Bardsley M; Heinsbroek E; Hope V; Phipps E
Public Health; 2021 Mar; 192():8-11. PubMed ID: 33601307
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
[TBL] [Abstract][Full Text] [Related]
18. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
Muncan B; Walters SM; Ezell J; Ompad DC
Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
[TBL] [Abstract][Full Text] [Related]
19. The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study.
Iryawan AR; Stoicescu C; Sjahrial F; Nio K; Dominich A
Harm Reduct J; 2022 Feb; 19(1):16. PubMed ID: 35148776
[TBL] [Abstract][Full Text] [Related]
20. Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study.
Kesten J; Hussey D; Lord C; Roberts L; Bayliss J; Erswell H; Preston A; Telfer M; Scott J; Harris M; Mellon D; Hickman M; MacArthur G; Fisher H
Harm Reduct J; 2023 Aug; 20(1):114. PubMed ID: 37608267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
